COC(=O)c1ccc(C23CC4(C2)[C@@H](c2ccccc2)N(Cc2ccc(-c5ccccc5)cc2)C[C@@H]4C3c2ccc(Cl)nc2)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?